Animal study · rats

IGF-1 LR3: about 2.5-fold more potent than IGF-I in catabolic rats

Checked against the paper Animal studyPublished by PepVault

The takeaway

In a rat model of steroid-driven wasting, IGF-1 LR3 did more per dose than plain IGF-I to limit weight and protein loss, though the rats did not fully recover.

Kind
Animal study
Studied in
Rats
Published
1992
Journal
Biochem J

What they tested

The team tested whether IGF-I and two modified forms, including IGF-1 LR3, could offset the body breakdown (a catabolic state) caused by dexamethasone in rats.

How the study was done

A comparative animal study in 150 g male rats given 20 micrograms of dexamethasone a day for 7 days, with IGF-I or one of two variants delivered by pumps placed under the skin. Results were compared with rats on dexamethasone alone and with pair-fed controls (rats given the same amount of food).

A woman in glasses at a kitchen table with a laptop, a mug and her phone

Model. Individual results vary.

PepVault for iPhone

Taking IGF-1 LR3? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

In rats, the highest IGF-I dose, 695 micrograms/day, led to a 6 g gain in body weight over 7 days, against a 19 g loss with dexamethasone alone and an 18 g gain in pair-fed controls. IGF-1 LR3 and a shortened variant, des(1-3)IGF-I, were each about 2.5-fold more potent than IGF-I, even though IGF-1 LR3's hold on the type 1 IGF receptor is 3-fold weaker than that of IGF-I. At the top IGF-I dose, 3-methylhistidine output, a marker of muscle protein breakdown, fell from 83.5 to 65.1 µmol/kg per 7 days, against 54.9 in pair-fed controls. Gut weight rose by up to 45%, most with the variants, and the added carcass weight came from nitrogen rather than fat.

What it doesn’t show

This was a short, 7-day study in rats with dexamethasone-induced breakdown, so it is not a human result. Carcass weight as a share of body weight stayed low in the treated rats, and part of the drop in breakdown may have come from the gut rather than muscle.

The paper

Tomas et al. Insulin-like growth factor-I (IGF-I) and especially IGF-I variants are anabolic in dexamethasone-treated rats. Biochem J. 1992.

The compound

More studies on IGF-1 LR3

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking IGF-1 LR3? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo